Natural cytotoxicity in malignant and premalignant cervical neoplasia and enhancement of cytotoxicity with interferon.

[1]  N. Ghossein,et al.  Natural cytotoxicity and interferon production in human cancer: deficient natural killer activity and normal interferon production in patients with advanced disease. , 1981, Journal of immunology.

[2]  J. Ortaldo,et al.  Natural killer cells: their roles in defenses against disease. , 1981, Science.

[3]  S. Pestka,et al.  Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma. , 1980, Annals of internal medicine.

[4]  T. Priestman.  INITIAL EVALUATION OF HUMAN LYMPHOBLASTOID INTERFERON IN PATIENTS WITH ADVANCED MALIGNANT DISEASE , 1980, The Lancet.

[5]  P. Lengyel,et al.  Mode of regulation of natural killer cell activity by interferon , 1980, The Journal of experimental medicine.

[6]  S. Targan,et al.  Interferon activation of "pre-spontaneous killer" (pre-SK) cells and alteration in kinetics of lysis of both "pre-SK" and active SK cells. , 1980, Journal of immunology.

[7]  J. Djeu,et al.  Augmentation of mouse natural killer activity and induction of interferon by tumor cells in vivo , 1980, The Journal of experimental medicine.

[8]  B. Bloom,et al.  Interferon as a mediator of human lymphocyte suppression , 1980, The Journal of experimental medicine.

[9]  E. Saksela,et al.  Fractionation, morphological and functional characterization of effector cells responsible for human natural killer activity against cell-line targets. , 1979, Cellular immunology.

[10]  P. Hersey,et al.  Low natural-killer-cell activity in familial melanoma patients and their relatives. , 1979, British Journal of Cancer.

[11]  H. Cantor,et al.  Direct evidence that natural killer cells in nonimmune spleen cell populations prevent tumor growth in vivo , 1979, The Journal of experimental medicine.

[12]  R. Kiessling,et al.  An Analysis of the Murine NK Cell as to Structure, Function and Biological Relevance , 1979, Immunological reviews.

[13]  D. Santoli,et al.  Mechanisms of Activation of Human Natural Killer Cells Against Tumor and Virus‐infected Cells , 1979, Immunological reviews.

[14]  C. Riccardi,et al.  Natural Killer Cells: Characteristics and Regulation of Activity , 1979, Immunological reviews.

[15]  H. Strander,et al.  INTERFERON THERAPY IN MYELOMATOSIS , 1979, The Lancet.

[16]  K. Sikora,et al.  Preliminary observations on the effect of human leukocyte interferon in non-Hodgkin's lymphoma. , 1978, The New England journal of medicine.

[17]  I. Gresser,et al.  Enhanced NK cell activity in mice injected with interferon and interferon inducers , 1978, Nature.

[18]  G. Trinchieri,et al.  Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulation , 1978, The Journal of experimental medicine.

[19]  G. Trinchieri,et al.  Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis , 1978, The Journal of experimental medicine.

[20]  O. Haller,et al.  Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo , 1977, Nature.

[21]  R. Herberman,et al.  A functional comparison of human Fc-receptor-bearing lymphocytes active in natural cytotoxicity and antibody-dependent cellular cytotoxicity. , 1977, Journal of immunology.

[22]  C. Lozzio,et al.  Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. , 1975, Blood.

[23]  R. Richart,et al.  A follow-up study of patients with cervical dysplasia. , 1969, American journal of obstetrics and gynecology.

[24]  O. Petersen.  Spontaneous course of cervical precancerous conditions. , 1956, American journal of obstetrics and gynecology.